Cargando…
The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes?
Background: The present research aimed to evaluate the effect on outcomes of immunonutrition (IMN) enteral formulas during the intensive care unit (ICU) stay. Methods: A multicenter prospective observational study was performed. Patient characteristics, disease severity, nutritional status, type of...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103218/ https://www.ncbi.nlm.nih.gov/pubmed/35565870 http://dx.doi.org/10.3390/nu14091904 |
_version_ | 1784707509301280768 |
---|---|
author | Lopez-Delgado, Juan Carlos Grau-Carmona, Teodoro Trujillano-Cabello, Javier García-Fuentes, Carlos Mor-Marco, Esther Bordeje-Laguna, Maria Luisa Portugal-Rodriguez, Esther Lorencio-Cardenas, Carol Vera-Artazcoz, Paula Macaya-Redin, Laura Martinez-Carmona, Juan Francisco Mateu-Campos, Lidón Gero-Escapa, Maria Gastaldo-Simeon, Rosa Vila-García, Belen Flordelis-Lasierra, José Luis Montejo-Gonzalez, Juan Carlos Servia-Goixart, Lluís |
author_facet | Lopez-Delgado, Juan Carlos Grau-Carmona, Teodoro Trujillano-Cabello, Javier García-Fuentes, Carlos Mor-Marco, Esther Bordeje-Laguna, Maria Luisa Portugal-Rodriguez, Esther Lorencio-Cardenas, Carol Vera-Artazcoz, Paula Macaya-Redin, Laura Martinez-Carmona, Juan Francisco Mateu-Campos, Lidón Gero-Escapa, Maria Gastaldo-Simeon, Rosa Vila-García, Belen Flordelis-Lasierra, José Luis Montejo-Gonzalez, Juan Carlos Servia-Goixart, Lluís |
author_sort | Lopez-Delgado, Juan Carlos |
collection | PubMed |
description | Background: The present research aimed to evaluate the effect on outcomes of immunonutrition (IMN) enteral formulas during the intensive care unit (ICU) stay. Methods: A multicenter prospective observational study was performed. Patient characteristics, disease severity, nutritional status, type of nutritional therapy and outcomes, and laboratory parameters were collected in a database. Statistical differences were analyzed according to the administration of IMN or other types of enteral formulas. Results: In total, 406 patients were included in the analysis, of whom 15.02% (61) received IMN. Univariate analysis showed that patients treated with IMN formulas received higher mean caloric and protein intake, and better 28-day survival (85.2% vs. 73.3%; p = 0.014. Unadjusted Hazard Ratio (HR): 0.15; 95% CI (Confidence Interval): 0.06–0.36; p < 0.001). Once adjusted for confounding factors, multivariate analysis showed a lower need for vasopressor support (OR: 0.49; 95% CI: 0.26–0.91; p = 0.023) and continuous renal replacement therapies (OR: 0.13; 95% CI: 0.01–0.65; p = 0.049) in those patients who received IMN formulas, independently of the severity of the disease. IMN use was also associated with higher protein intake during the administration of nutritional therapy (OR: 6.23; 95% CI: 2.59–15.54; p < 0.001), regardless of the type of patient. No differences were found in the laboratory parameters, except for a trend toward lower triglyceride levels (HR: 0.97; 95% CI: 0.95–0.99; p = 0.045). Conclusion: The use of IMN formulas may be associated with better outcomes (i.e., lower need for vasopressors and continuous renal replacement), together with a trend toward higher protein enteral delivery during the ICU stay. These findings may ultimately be related to their modulating effect on the inflammatory response in the critically ill. NCT Registry: 03634943. |
format | Online Article Text |
id | pubmed-9103218 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91032182022-05-14 The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes? Lopez-Delgado, Juan Carlos Grau-Carmona, Teodoro Trujillano-Cabello, Javier García-Fuentes, Carlos Mor-Marco, Esther Bordeje-Laguna, Maria Luisa Portugal-Rodriguez, Esther Lorencio-Cardenas, Carol Vera-Artazcoz, Paula Macaya-Redin, Laura Martinez-Carmona, Juan Francisco Mateu-Campos, Lidón Gero-Escapa, Maria Gastaldo-Simeon, Rosa Vila-García, Belen Flordelis-Lasierra, José Luis Montejo-Gonzalez, Juan Carlos Servia-Goixart, Lluís Nutrients Article Background: The present research aimed to evaluate the effect on outcomes of immunonutrition (IMN) enteral formulas during the intensive care unit (ICU) stay. Methods: A multicenter prospective observational study was performed. Patient characteristics, disease severity, nutritional status, type of nutritional therapy and outcomes, and laboratory parameters were collected in a database. Statistical differences were analyzed according to the administration of IMN or other types of enteral formulas. Results: In total, 406 patients were included in the analysis, of whom 15.02% (61) received IMN. Univariate analysis showed that patients treated with IMN formulas received higher mean caloric and protein intake, and better 28-day survival (85.2% vs. 73.3%; p = 0.014. Unadjusted Hazard Ratio (HR): 0.15; 95% CI (Confidence Interval): 0.06–0.36; p < 0.001). Once adjusted for confounding factors, multivariate analysis showed a lower need for vasopressor support (OR: 0.49; 95% CI: 0.26–0.91; p = 0.023) and continuous renal replacement therapies (OR: 0.13; 95% CI: 0.01–0.65; p = 0.049) in those patients who received IMN formulas, independently of the severity of the disease. IMN use was also associated with higher protein intake during the administration of nutritional therapy (OR: 6.23; 95% CI: 2.59–15.54; p < 0.001), regardless of the type of patient. No differences were found in the laboratory parameters, except for a trend toward lower triglyceride levels (HR: 0.97; 95% CI: 0.95–0.99; p = 0.045). Conclusion: The use of IMN formulas may be associated with better outcomes (i.e., lower need for vasopressors and continuous renal replacement), together with a trend toward higher protein enteral delivery during the ICU stay. These findings may ultimately be related to their modulating effect on the inflammatory response in the critically ill. NCT Registry: 03634943. MDPI 2022-05-01 /pmc/articles/PMC9103218/ /pubmed/35565870 http://dx.doi.org/10.3390/nu14091904 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lopez-Delgado, Juan Carlos Grau-Carmona, Teodoro Trujillano-Cabello, Javier García-Fuentes, Carlos Mor-Marco, Esther Bordeje-Laguna, Maria Luisa Portugal-Rodriguez, Esther Lorencio-Cardenas, Carol Vera-Artazcoz, Paula Macaya-Redin, Laura Martinez-Carmona, Juan Francisco Mateu-Campos, Lidón Gero-Escapa, Maria Gastaldo-Simeon, Rosa Vila-García, Belen Flordelis-Lasierra, José Luis Montejo-Gonzalez, Juan Carlos Servia-Goixart, Lluís The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes? |
title | The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes? |
title_full | The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes? |
title_fullStr | The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes? |
title_full_unstemmed | The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes? |
title_short | The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes? |
title_sort | effect of enteral immunonutrition in the intensive care unit: does it impact on outcomes? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103218/ https://www.ncbi.nlm.nih.gov/pubmed/35565870 http://dx.doi.org/10.3390/nu14091904 |
work_keys_str_mv | AT lopezdelgadojuancarlos theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT graucarmonateodoro theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT trujillanocabellojavier theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT garciafuentescarlos theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT mormarcoesther theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT bordejelagunamarialuisa theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT portugalrodriguezesther theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT lorenciocardenascarol theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT veraartazcozpaula theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT macayaredinlaura theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT martinezcarmonajuanfrancisco theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT mateucamposlidon theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT geroescapamaria theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT gastaldosimeonrosa theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT vilagarciabelen theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT flordelislasierrajoseluis theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT montejogonzalezjuancarlos theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT serviagoixartlluis theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT theeffectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT lopezdelgadojuancarlos effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT graucarmonateodoro effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT trujillanocabellojavier effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT garciafuentescarlos effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT mormarcoesther effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT bordejelagunamarialuisa effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT portugalrodriguezesther effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT lorenciocardenascarol effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT veraartazcozpaula effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT macayaredinlaura effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT martinezcarmonajuanfrancisco effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT mateucamposlidon effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT geroescapamaria effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT gastaldosimeonrosa effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT vilagarciabelen effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT flordelislasierrajoseluis effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT montejogonzalezjuancarlos effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT serviagoixartlluis effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes AT effectofenteralimmunonutritionintheintensivecareunitdoesitimpactonoutcomes |